Cargando…

Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma

Obstructive sleep apnoea (OSA)-induced chronic intermittent hypoxia (CIH) has been considered a risk factor for severe asthma. Airway remodelling, which could be modulated by autophagy, plays a key role in severe asthma. However, the extent of autophagy’s involvement in CIH-potentiated airway remode...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian Ping, Wang, Yi, Li, Shi Qi, Zhang, Jia Qi, Lin, Ying Ni, Sun, Xian Wen, Zhou, Li Na, Zhang, Liu, Lu, Fang Ying, Ding, Yong Jie, Li, Qing Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545676/
https://www.ncbi.nlm.nih.gov/pubmed/37783703
http://dx.doi.org/10.1038/s41420-023-01662-0
_version_ 1785114716889153536
author Zhou, Jian Ping
Wang, Yi
Li, Shi Qi
Zhang, Jia Qi
Lin, Ying Ni
Sun, Xian Wen
Zhou, Li Na
Zhang, Liu
Lu, Fang Ying
Ding, Yong Jie
Li, Qing Yun
author_facet Zhou, Jian Ping
Wang, Yi
Li, Shi Qi
Zhang, Jia Qi
Lin, Ying Ni
Sun, Xian Wen
Zhou, Li Na
Zhang, Liu
Lu, Fang Ying
Ding, Yong Jie
Li, Qing Yun
author_sort Zhou, Jian Ping
collection PubMed
description Obstructive sleep apnoea (OSA)-induced chronic intermittent hypoxia (CIH) has been considered a risk factor for severe asthma. Airway remodelling, which could be modulated by autophagy, plays a key role in severe asthma. However, the extent of autophagy’s involvement in CIH-potentiated airway remodelling remains largely unexplored. Furthermore, we had found that angiotensin-(1-7) [Ang-(1-7)] has therapeutic effects on airway remodelling in asthma, but the underlying mechanism is either unclear. This study aimed to explore how CIH aggravates asthma and mechanism of protective effects of Ang-(1-7) on airway remodelling, with a focus on autophagy. We observed that CIH promoted epithelial-to-mesenchymal transition (EMT), indicated by elevated EMT and fibrotic markers such as Snail and Collagen IV, both in vitro and in vivo. CIH intensified cell autophagy, evident from increased LC3B expression and reduced p62 levels. Ang-(1-7) reversed the CIH-enhanced expression of Snail, Collagen IV, and LC3B. To explore how CIH enhanced autophagy in cellular and animal model of asthma, overexpression of hypoxia-inducible factor 1-alpha (HIF-1α) and Thrombospondin 1 (THBS1) were identified in CIH-exposure mice lung compared with normal mice lung tissues from the GEO database. Finally, through chromatin immunoprecipitation and immunoprecipitation assays, we verified that Ang-(1-7) inhibits CIH-induced binding of HIF-1α to the promoter of THBS1, and also disrupts the protein-protein interaction between THBS1 and the autophagy-associated protein Beclin 1 (BECN1), ultimately leading to autophagy inhibition. Our findings suggest that exogenous Ang-(1-7) can inhibit autophagy via HIF-1α/THBS1/BECN1 axis, thereby alleviating CIH-enhanced airway remodelling in asthma. These findings imply the potential therapeutic effect of Ang-(1-7) in asthma with OSA.
format Online
Article
Text
id pubmed-10545676
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105456762023-10-04 Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma Zhou, Jian Ping Wang, Yi Li, Shi Qi Zhang, Jia Qi Lin, Ying Ni Sun, Xian Wen Zhou, Li Na Zhang, Liu Lu, Fang Ying Ding, Yong Jie Li, Qing Yun Cell Death Discov Article Obstructive sleep apnoea (OSA)-induced chronic intermittent hypoxia (CIH) has been considered a risk factor for severe asthma. Airway remodelling, which could be modulated by autophagy, plays a key role in severe asthma. However, the extent of autophagy’s involvement in CIH-potentiated airway remodelling remains largely unexplored. Furthermore, we had found that angiotensin-(1-7) [Ang-(1-7)] has therapeutic effects on airway remodelling in asthma, but the underlying mechanism is either unclear. This study aimed to explore how CIH aggravates asthma and mechanism of protective effects of Ang-(1-7) on airway remodelling, with a focus on autophagy. We observed that CIH promoted epithelial-to-mesenchymal transition (EMT), indicated by elevated EMT and fibrotic markers such as Snail and Collagen IV, both in vitro and in vivo. CIH intensified cell autophagy, evident from increased LC3B expression and reduced p62 levels. Ang-(1-7) reversed the CIH-enhanced expression of Snail, Collagen IV, and LC3B. To explore how CIH enhanced autophagy in cellular and animal model of asthma, overexpression of hypoxia-inducible factor 1-alpha (HIF-1α) and Thrombospondin 1 (THBS1) were identified in CIH-exposure mice lung compared with normal mice lung tissues from the GEO database. Finally, through chromatin immunoprecipitation and immunoprecipitation assays, we verified that Ang-(1-7) inhibits CIH-induced binding of HIF-1α to the promoter of THBS1, and also disrupts the protein-protein interaction between THBS1 and the autophagy-associated protein Beclin 1 (BECN1), ultimately leading to autophagy inhibition. Our findings suggest that exogenous Ang-(1-7) can inhibit autophagy via HIF-1α/THBS1/BECN1 axis, thereby alleviating CIH-enhanced airway remodelling in asthma. These findings imply the potential therapeutic effect of Ang-(1-7) in asthma with OSA. Nature Publishing Group UK 2023-10-02 /pmc/articles/PMC10545676/ /pubmed/37783703 http://dx.doi.org/10.1038/s41420-023-01662-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Zhou, Jian Ping
Wang, Yi
Li, Shi Qi
Zhang, Jia Qi
Lin, Ying Ni
Sun, Xian Wen
Zhou, Li Na
Zhang, Liu
Lu, Fang Ying
Ding, Yong Jie
Li, Qing Yun
Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma
title Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma
title_full Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma
title_fullStr Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma
title_full_unstemmed Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma
title_short Exogenous Ang-(1-7) inhibits autophagy via HIF-1α/THBS1/BECN1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma
title_sort exogenous ang-(1-7) inhibits autophagy via hif-1α/thbs1/becn1 axis to alleviate chronic intermittent hypoxia-enhanced airway remodelling of asthma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545676/
https://www.ncbi.nlm.nih.gov/pubmed/37783703
http://dx.doi.org/10.1038/s41420-023-01662-0
work_keys_str_mv AT zhoujianping exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT wangyi exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT lishiqi exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT zhangjiaqi exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT linyingni exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT sunxianwen exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT zhoulina exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT zhangliu exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT lufangying exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT dingyongjie exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma
AT liqingyun exogenousang17inhibitsautophagyviahif1athbs1becn1axistoalleviatechronicintermittenthypoxiaenhancedairwayremodellingofasthma